News

23andMe bankruptcy prompts Cornyn-Grassley-Klobuchar bipartisan bill to protect sensitive genetic data
Republican Sen. John Cornyn and Democratic Sen. Amy Klobuchar are rolling out a measure to protect sensitive genetic data ...
Does the 23andMe Acquisition Make Regeneron a Buy Now?
Regeneron (NASDAQ: REGN) entered an agreement to acquire 23andMe for $256 million, which is a tiny fraction of its previous ...
23andMe to Be Bought by Biotech Company for $256 Million
Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer ...
23andMe was once worth $6 billion. What's left of the DNA testing startup is being bought for $256 million.
Regeneron is buying the assets of 23andMe, which filed for Chapter 11 bankruptcy in March after facing a series of hurdles ...
Genetic data will be safeguarded with 23andMe sale, drugmaker vows
The pharmaceutical giant plans to continue offering 23andMe’s DNA testing service and pledged to adopt its privacy practices ...
23andMe sale reveals what your genetic data is worth. It’s less than you think
The price tag of this acquisition suggests that the value of genetic data is declining. Back in 2018, the drug company GSK ...
Regeneron to buy 23andMe out of bankruptcy for $256 million
Regeneron, a biotech company, will acquire 23andMe for $256 million and vowed to comply with the genetic testing company's ...
Bailey issues consumer alert to 23andMe customers following bankruptcy filing
Missouri Attorney General Andrew Bailey is alerting residents after biotechnology company 23andMe filed for bankruptcy in ...